Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-26-004133
Filing Date
2026-07-01
Accepted
2026-06-30 19:36:34
Documents
41
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K agtx_10k.htm   iXBRL 10-K 546871
2 CERTIFICATION agtx_ex311.htm EX-31.1 10545
3 CERTIFICATION agtx_ex312.htm EX-31.2 10619
4 CERTIFICATION agtx_ex321.htm EX-32.1 3883
5 COMPENSATION RECOUPMENT POLICY agtx_ex971.htm EX-97.1 36551
11 agtx_10kimg4.jpg GRAPHIC 2877
12 agtx_10kimg3.jpg GRAPHIC 4631
  Complete submission text file 0001477932-26-004133.txt   2312634

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA agtx-20260331.xsd EX-101.SCH 20271
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20260331_lab.xml EX-101.LAB 138016
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20260331_cal.xml EX-101.CAL 27944
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20260331_pre.xml EX-101.PRE 106870
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20260331_def.xml EX-101.DEF 32835
45 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10k_htm.xml XML 205708
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

EIN.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55383 | Film No.: 261142140
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)